242 related articles for article (PubMed ID: 1292341)
1. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone.
Joffe P; Hyldstrup L; Heaf JG; Pødenphant J; Henriksen JH
Am J Nephrol; 1992; 12(6):419-24. PubMed ID: 1292341
[TBL] [Abstract][Full Text] [Related]
2. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
Joffe P; Heaf JG; Jensen C
Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
4. Type I procollagen propeptide in patients on CAPD: its relationships with bone histology, osteocalcin, and parathyroid hormone.
Joffe P; Heaf JG; Jensen LT
Nephrol Dial Transplant; 1995 Oct; 10(10):1912-7. PubMed ID: 8592603
[TBL] [Abstract][Full Text] [Related]
5. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
6. Osteocalcin: a non-invasive index of metabolic bone disease in patients treated by CAPD.
Joffe P; Heaf JG; Hyldstrup L
Kidney Int; 1994 Sep; 46(3):838-46. PubMed ID: 7996805
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
Malluche HH; Faugere MC; Fanti P; Price PA
Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
[TBL] [Abstract][Full Text] [Related]
8. Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy.
Mazzaferro S; Coen G; Ballanti P; Bondatti F; Bonucci E; Pasquali M; Sardella D; Tomei E; Taggi F
Nephron; 1990; 56(3):261-6. PubMed ID: 2077408
[TBL] [Abstract][Full Text] [Related]
9. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
Buccianti G; Bianchi ML; Valenti G
Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
[TBL] [Abstract][Full Text] [Related]
10. Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.
Keronen S; Martola L; Finne P; Burton IS; Kauppila L; Kröger H; Larsson TE; Honkanen E
Clin Nephrol; 2016 Mar; 85(3):127-34. PubMed ID: 26833298
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
12. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
13. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
Shigematsu T; Kawaguchi Y; Kubo H; Nakayama M; Kato N; Yamamoto H; Osaka N; Hayakawa H; Ogawa A; Sakai O
Adv Perit Dial; 1996; 12():250-6. PubMed ID: 8865914
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.
Pasadakis P; Thodis E; Mourvati E; Euthimiadou A; Margaritis D; Manavis J; Vargemezis V
Adv Perit Dial; 1996; 12():245-9. PubMed ID: 8865913
[TBL] [Abstract][Full Text] [Related]
16. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
[TBL] [Abstract][Full Text] [Related]
17. Extent of alkaline phosphatase cytochemistry vs. extent of tetracycline fluorescence in the evaluation of histodynamic variables of bone formation.
Ballanti P; Coen G; Taggi F; Mazzaferro S; Perruzza I; Bonucci E
Bone; 1995 May; 16(5):493-8. PubMed ID: 7654463
[TBL] [Abstract][Full Text] [Related]
18. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
[TBL] [Abstract][Full Text] [Related]
19. Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.
Geng Z; Monier-Faugere MC; Bauss F; Malluche HH
Clin Nephrol; 2000 Jul; 54(1):45-53. PubMed ID: 10939756
[TBL] [Abstract][Full Text] [Related]
20. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
